Cimetidine
21 NDCs across 5 manufacturers|21 Generic,0 Brand
Cimetidine is used to treat duodenal ulcer, dyspepsia, peptic esophagitis, gastroesophageal reflux, heartburn and helicobacter infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved May 17, 1994. FDA's Orange Book lists 20 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6 million on Cimetidine across 104,000 claims for 27,000 beneficiaries.
Cimetidine is available as 21 NDCs from 5 manufacturers (21 generic, 0 brand), with NADAC prices from $0.20 to $0.72 per EA — the most expensive product costs about 3.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
21
21G / 0B
Manufacturers
5
competing in market
Price Spread
$0.20 – $0.72
per EA
7d Activity
avg +0.7% WoW · of 21 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Histamine-2 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing CIMETIDINE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CIMETIDINE 800 MG TABLET | $0.7208 per EA | -3.05% |
CIMETIDINE 800 MG TABLET | $0.7208 per EA | -3.05% |
CIMETIDINE 800 MG TABLET | $0.7208 per EA | -3.05% |
CIMETIDINE 800 MG TABLET | $0.7208 per EA | -3.05% |
CIMETIDINE 800 MG TABLET | $0.7208 per EA | -3.05% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 400 MG TABLET | $0.3193 per EA | +4.08% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 300 MG TABLET | $0.2358 per EA | +2.34% |
CIMETIDINE 200 MG TABLET | $0.2042 per EA | -2.25% |
CIMETIDINE 200 MG TABLET | $0.2042 per EA | -2.25% |
CIMETIDINE 200 MG TABLET | $0.2042 per EA | -2.25% |
CIMETIDINE 200 MG TABLET | $0.2042 per EA | -2.25% |
Frequently Asked Questions
What is Cimetidine used to treat?
Cimetidine is used to treat duodenal ulcer, dyspepsia, peptic esophagitis, gastroesophageal reflux, heartburn and helicobacter infections, per the National Library of Medicine's MED-RT classification.
When did Cimetidine become available as a generic?
FDA approved the first generic Cimetidine (ANDA) on May 17, 1994. The Orange Book currently lists 20 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cimetidine?
In 2024, Medicare Part D spent $6 million on Cimetidine across 104,000 claims for 27,000 beneficiaries.
How many Cimetidine products are on the market?
The Cimetidine drug market contains 21 NDCs from 5 manufacturers — 21 generic and 0 brand products.
What is the price range for Cimetidine?
NADAC reference prices for Cimetidine range from $0.2042 to $0.7208 per EA — the most expensive product costs about 3.5× the cheapest.
Which manufacturers make Cimetidine?
5 manufacturers list Cimetidine in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (5), Chartwell RX LLC (4), Mylan Pharmaceuticals Inc. (4), Aurobindo Pharma Limited (4), Bionpharma Inc. (4).
How has the price of Cimetidine changed recently?
Over the past 7 days, 12 Cimetidine NDCs rose and 9 fell, with a market-wide average change of +0.7%.